Chargement en cours...
Niraparib in ovarian cancer: results to date and clinical potential
Ovarian cancer is the first cause of death from gynaecological malignancy. Germline mutation in BRCA1 and 2, two genes involved in the mechanisms of reparation of DNA damage, are showed to be related with the incidence of breast and ovarian cancer, both sporadic and familiar. PARP is a family of enz...
Enregistré dans:
| Publié dans: | Ther Adv Med Oncol |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5564880/ https://ncbi.nlm.nih.gov/pubmed/29081841 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834017718775 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|